-
Published 6/14/2019
Chirra P, Leo P, Yim M, Bloch BN, Rastinehad AR, Purysko A, Rosen M, Madabhushi A, Viswanath SE. Multisite evaluation of radiomic feature reproducibility and discriminability for identifying peripheral zone prostate tumors on MRI. J Med Imaging (Bellingham). 2019 Apr; 6(2):024502. PMID: 31259199.
-
Published 4/5/2019
Braman N, Prasanna P, Whitney J, Singh S, Beig N, Etesami M, Bates DDB, Gallagher K, Bloch BN, Vulchi M, Turk P, Bera K, Abraham J, Sikov WM, Somlo G, Harris LN, Gilmore H, Plecha D, Varadan V, Madabhushi A. Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer. JAMA Netw Open. 2019 04 05; 2(4):e192561. PMID: 31002322.
-
Published 2/28/2019
Viswanath SE, Chirra PV, Yim MC, Rofsky NM, Purysko AS, Rosen MA, Bloch BN, Madabhushi A. Comparing radiomic classifiers and classifier ensembles for detection of peripheral zone prostate tumors on T2-weighted MRI: a multi-site study. BMC Med Imaging. 2019 02 28; 19(1):22. PMID: 30819131.
-
Published 8/6/2018
Lee CL, Dietrich MC, Desai UG, Das A, Yu S, Xiang HF, Jaffe CC, Hirsch AE, Bloch BN. A 3D-Printed Patient-Specific Phantom for External Beam Radiation Therapy of Prostate Cancer. J Eng Sci Med Diagn Ther. 2018 Nov; 1(4). PMID: 30775692.
-
Published 12/13/2017
Kan CK, Qureshi MM, Gupta A, Agarwal A, Gignac GA, Bloch BN, Thoreson N, Hirsch AE. Risk factors involved in treatment delays and differences in treatment type for patients with prostate cancer by risk category in an academic safety net hospital. Adv Radiat Oncol. 2018 Apr-Jun; 3(2):181-189. PMID: 29904743.